Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary

November 6, 2025

New York Stock Exchange US Financials Insurance earnings 51 min

Earnings Call Speaker Segments

Rob Phillips

executive
#1

Thanks, Operator, and I appreciate all of you being on Abacus Global Management's call covering results for the third quarter of 2025. Joining me are Jay Jackson, our Chairman and Chief Executive Officer; Elena Plesco, our Chief capital Officer; and Bill McCauley, our Chief Financial Officer. At 4:05 P.M. Eastern Time this afternoon, Abacus Global Management put out its third quarter 2025 results. On today's call, participants will have the chance to pose questions regarding those results. Prior to starting, Abacus Global Management directs those listening to the investor webpage, ir-abacusgm.com, where the press release, investor information, and filings with the U.S. SEC can be found, offering discussion of risks and uncertainties capable of affecting the business. Abacus Global Management particularly directs listeners to the presentation furnished today on Form 8-K with the U.S. Securities and Exchange Commission and wishes to remind listeners that certain comments made today might include forward-looking statements and, because of that, will carry risks and uncertainties that, should they occur, could materially affect results. For additional detail on the risks, uncertainties, and assumptions tied to forward-looking statements, kindly consult Abacus Global Management's public filings. Throughout this call, we will cite certain non-GAAP financial measures. While we regard these measures as offering helpful supplemental information concerning our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles or GAAP. Kindly review our public filings for further detail on our non-GAAP financial measures, including references to comparable GAAP measures. Having said that, I would now like to hand the call over to Jay Jackson, Chief Executive Officer.

Jay Jackson

executive
#2

Thanks, and good afternoon to all of you. It's my pleasure to share that Abacus has posted yet another record quarter — our 10th in a row surpassing consensus estimates — which keeps us solidly on pace toward our long-term growth objectives. Results for our third quarter were equally strong. Year-over-year, total revenue climbed 124%, reaching $63 million. Adjusted net income grew 60%, hitting $23.6 million, while adjusted EBITDA was up 127%, totaling $37.9 million. Given how well Q3 went, we're again able to raise our 2025 guidance, now to $80 million to $84 million, which works out to 72% to 81% growth year-over-year for 2025. There's something I want to highlight: Abacus has reached a major turning point, and it shows just how committed we are to delivering value to shareholders over the long haul. This morning, we said we would start paying a yearly dividend of $0.20 per share, and we also launched a buyback program worth $10 million. These steps represent a pivotal chapter for Abacus — they demonstrate that we believe in our strategy and that it's proving out as we continue generating earnings that are sustainable and recurring. Our balance sheet and our ability to produce cash are both at all-time highs, driven by more capital flowing into our longevity Funds, higher fee income, and margins that keep getting wider. During the release, we noted that our strong capital base allows us to support continued expansion through fresh Originations, value-added acquisitions, and investments in technology, while also giving capital back to shareholders. I feel enormous pride in what our team has achieved and in the solid standing their relentless commitment has established for Abacus. Introducing a dividend alongside a buyback does not represent a strategic shift — rather, it is the logical next step in our strategy. As recurring revenues are expected to eventually account for approximately 70% of overall revenue, our approach to allocating capital is designed to strike a balance between investing in growth and delivering dependable returns to shareholders. Equally significant, through these steps Abacus moves closer to the standard set by top publicly listed alternative asset managers — numerous of whom have demonstrated over many years that earnings generated from recurring fees are capable of supporting both robust expansion and substantial returns of capital. Thanks to this disciplined method, we are assured of continuing to grow our platform, reinforce our competitive standing, and allow investors to gain directly from how predictable and durable our profits are. In my view, this is a good moment to reflect on how Abacus compares with the group of public asset managers we measure ourselves against. What the figures show is unambiguous — something I think merits your careful consideration. When we examine our cohort of exchange-listed alternative asset managers, Abacus continues to distinguish itself across the financial measures that matter most. When it comes to year-over-year revenue growth, we're five times ahead of our public peer group. At Abacus, revenue is up 124% year over year. For comparison, during that same stretch, other publicly traded alternative managers posted average year-over-year revenue growth in the 20% to 30% range. None of this is forecasting or wishful thinking — it's what we're actually delivering, quarter in and quarter out, which shows both our leadership in the market and how much room we have to grow. No other asset manager has a stronger growth trajectory than Abacus, and we expect to keep outrunning public peers, thanks to disciplined execution, solid Origination, and rising investor appetite for uncorrelated returns. What sets Abacus apart is that its fundamentals are accelerating even as visibility continues to improve, which makes the path to durable value creation extremely clear. Turning to the wider valuation landscape, the gap looks even bigger. On average, publicly traded alternative asset managers change hands at about 20 times their estimated 2025 earnings. Abacus, by contrast, changes hands in the mid-single digits. That gap amounts to a steep discount relative to our peers, and it gives investors an opening. Valuation comparisons can only tell us so much, yet strong fundamentals plus steady execution plus a near-term disconnect in the share price add up to a pattern we have seen before. It is a pattern that, historically, has resolved in favor of the fundamentals. Here at Abacus, we keep broadening our revenue streams as assets under management grow. So far this year, we have brought in $468 million across every one of our fund strategies, and inflows during Q3 came to $102 million. We are dedicated to growing our AUM and to drawing a larger share of total revenue from recurring, fee-based sources, which by their nature earn higher valuations; let me put it plainly. Making sure the market grasps this evolution is my responsibility. Operationally we are delivering and beating expectations again and again, yet we still need to do more to convey how deep our business model runs and how durable our results are. Starting with the prior quarter's results, we rolled out new KPIs designed specifically to streamline our message and to make the Abacus story clearer and easier to follow. We are devoted to communication that is clear and consistent, helping investors see what powers our business and how, together, we gauge success. We also achieved meaningful progress in growing our investor outreach efforts. From now through the close of 2025, and carrying on into 2026, you will find Abacus showing up at additional conferences, at more speaking engagements, and with greater visibility via television and media advertising. Across institutional and retail channels alike, our management team stays fully reachable and involved, putting transparency first and building relationships for the long haul. Beyond that, we're continuing to pursue acquisitions that are strategic and accretive — deals that sharpen our competitive edge and expand our Origination business as well as our wealth platform around the world. A clear example is the transaction we recently made public involving AccuQuote. Through a single digital platform, this leading online life insurance brokerage lets consumers obtain quotes from multiple carriers. From both a strategic and a financial standpoint, the deal is accretive: it introduces a fresh digital Origination channel, stretches our reach across the client lifecycle, and supports the accelerating growth we're seeing in policy Origination and asset acquisition volumes. Over the short term, AccuQuote contributes a modest lift to revenue and profit. Looking further ahead, it will serve as a scalable growth engine that channels directly into our underwriting and asset management operations. Thanks to our robust free cash generation and strong returns on invested capital, we have the flexibility to keep funding strategic initiatives while also returning capital to shareholders. Now let me turn to today's market conditions. Our longevity-based assets have essentially no correlation to traditional markets. What drives their performance is actuarial and demographic trends, not market mood or interest rate cycles. That structural distinction delivers consistent, non-correlated exposure at precisely the moment diversification matters most. On that note, once the quarter had closed, we hit a significant milestone: a $50 million securitization product note rated above investment grade, backed by life insurance assets and sold to institutional investors, insurance companies, and banks. What this deal represents is the start of a funding mechanism that can scale and recur, and at the same time it confirms just how strong institutional appetite is for longevity-linked assets with lower correlation. Beyond that, it reinforces where Abacus stands — on top in a sector subject to tight rules — and favorable population shifts expected to endure for many decades provide the foundation; from our perspective, this deal is just the initial one among many to come, since we continue building out the framework required to transform this into something repeatable and scalable within our long-term funding approach and cost of capital, all while broadening how we reach bank and insurance investors, converting assets held on the balance sheet into ongoing service and fee revenue, and delivering further gains in profitability and return on equity. To wrap up, the numbers tell the story on their own: ten straight quarters of robust earnings increases, returns on capital that lead the industry, growing recurring revenue, and a clear route toward enhanced visibility and scale. Turning these fundamentals into value for shareholders over the long haul remains what we're centered on. At this point, I'll pass things over to Elena Plesco, who serves as our Chief capital Officer, and she'll walk everyone through our key performance indicators along with the capital structure in greater depth.

Elena Plesco

executive
#3

Thanks, Jay. I want to call out a few strategic milestones from recently, and after that get into our balance sheet efficiency metrics and KPIs. As Jay said, on October 22nd we announced a major milestone; we completed the sale of $50 million in securitized life insurance assets, structured as a collateralized note with an investment-grade rating and a mid-single digit yield; for Abacus, this deal marks a strategic breakthrough on several fronts. First, it opens a new institutional distribution channel that sits alongside our current monetization pathways, giving us access to a wider universe of capital providers, such as banks, insurance companies, and fixed-income investors, who generally need rated structures. Second, it confirms our underwriting and portfolio construction capabilities. To be specific, obtaining an investment-grade rating shows that our credit and actuarial processes satisfy institutional standards. Third, this transaction builds a scalable template for later executions, which could enhance our overall capital efficiency as we build a track record in the securitized products market. Lastly, by proving that life insurance assets can be packaged into rated instruments carrying mid-single digit yields, we are in effect widening the addressable market for these assets and strengthening Abacus's position as a leader in bringing institutional-grade structures to the longevity space. This isn't merely a one-time financing event. It's a proof of concept that unlocks meaningful optionality in how we consider asset monetization and balance sheet management going forward. Now, moving to our operational metrics. During the last quarter, we said our long-term target for portfolio turnover is 1.5 to 2x. For Q3 2025, our annualized turnover ratio came in at 2x. That's consistent with expectations. Another important indicator of how efficiently we manage the balance sheet is our capacity to monetize seasoned policies at optimal timing. In the third quarter of 2025, policies we sold had spent an average of 363 days on our balance sheet, versus 253 days for policies we still own, which highlights our ability to rotate mature inventory efficiently while maintaining overall portfolio quality. This 110-day delta for sold policies confirms our proactive approach of realizing gains on well-seasoned positions instead of doing reactive selling. This metric plainly shows that we manage the balance sheet strategically rather than just churning newer acquisitions. As we've said before, certain assets stay on our balance sheet longer. Those are our best ideas. At the end of Q3 2025, 19.6% of our total portfolio value, including cash, had been held for over 365 days. These seasoned holdings keep a weighted average grade that reflects their low risk and strong credit profile, a weighted average life expectancy of 49 months, and a weighted average age of 86 years, which underscores the quality of our long-term hold decisions. This concentration in our best ideas reflects our disciplined approach to portfolio construction and our confidence in our underwriting capabilities. Finally, while portfolio turnover demonstrates capital efficiency, the profitability of our sales matters just as much, measured by the difference between what Abacus paid to originate a policy and the actual sales price received. For the third quarter of 2025, the average gain we realized on each sale came to 36.9%. As is evident, during this quarter we managed to resell inventory acquired 12 months earlier, at a time when interest rates were different — which confirms that our approach to managing the balance sheet strategically, along with strict cost control across our operations, is working; having said that. At this point I'll pass things to Bill McCauley, our CFO, so he can walk through the details of what we recorded in the third quarter.

Bill McCauley

executive
#4

Thanks, Elena. Hi, everyone. As Jay said, we turned in yet another excellent quarter when it comes to both revenue growth and profitability. In Q3, total revenue rose 124%, reaching $63 million, up from $28.1 million during the same period a year earlier. The drivers behind that increase were strong Life Solutions results, higher asset management fees, and what our technology services business contributed. Our Life Solutions segment keeps gaining from our extremely efficient Origination platform along with our active trading division. capital deployed rose 10%, hitting $102.4 million in Q3, versus $93.2 million a year ago. In addition to deployment, we enjoyed another robust quarter when it comes to realized gains. Realized gains for Q3 2025 came to $46.4 million, mainly due to selling 282 policies to 17 separate counterparties. As of September 30, we hold 522 policies valued at $424.7 million on our balance sheet. Drawing on our historical track record, we anticipate monetizing these assets in roughly six months, with spreads averaging above 20%. We remain happy with our asset management segment, now in its third full quarter after the Q4 2024 acquisitions. This business produced $8.6 million in revenue during Q3 and brought in $102 million of new inflows, which shows the worth of our strategic M&A activity. Now for expenses, total operating expenses, excluding unrealized and realized gains and losses on investments and the change in fair value of debt, came to $32.9 million, versus $19.4 million a year earlier. That rise reflects operating expenses from the companies we acquired, greater G&A, higher depreciation and amortization, and strategic marketing investments meant to support our growth trajectory. Usually, we see returns on marketing spend within 90 to 120 days. On an adjusted basis, excluding non-cash stock compensation, business acquisition costs, amortization, and changes in warrant liability fair value, net income was $23.6 million, versus $14.7 million a year ago. Adjusted EBITDA climbed 127% to $37.9 million against $16.7 million in the prior year, with margins of 60.2%, in line with the comparable period. GAAP net income attributable to stockholders was $7.1 million, compared with a net loss of $5.1 million a year earlier. Higher revenues across all segments drove that improvement, partly offset by greater operating costs and interest expense. Our balance sheet metrics keep showing our highly profitable business model. Annualized adjusted return on equity was 22%, and annualized adjusted return on invested capital was 21% for the quarter. As of September 30th, we held $86.4 million in cash and cash equivalents and $424.7 million in balance sheet policy assets. As Jay noted in his opening remarks, because of our strong performance through September, we are raising our full-year adjusted net income guidance on a gross basis to a range of $80 million-$84 million, up from our earlier range of $74 million-$80 million. That represents growth of 72%-81%, compared to 2024 adjusted net income of $46.5 million; in summary, we keep delivering record revenue growth while considerably expanding profitability on an adjusted basis. We're seeing solid performance from our diversified business model in every segment, and we're set up nicely to keep succeeding. At this point I'll hand things back to Jay Jackson, our CEO, for some closing remarks.

Jay Jackson

executive
#5

Thank you, Bill. Before handing things back to the operator so you can ask your questions, I'd like to wrap up by underscoring the qualities that set Abacus apart; within one of the most attractive areas of alternative asset management, longevity-based investing, we act with discipline and clear purpose. The numbers keep making our case on their own: record profitability, steady growth, and widening recognition in the market. When investors want stability and genuine diversification, Abacus is different, providing uncorrelated assets, returns that scale, and a platform built to generate value over the long run. There's an obvious gap between our fundamentals and where our valuation sits today; that gap is also among our biggest opportunities. We're tackling it directly via transparent communication, active engagement with investors, and ongoing execution throughout each area of our business. On that note, our dividend and buybacks convey an unmistakable message: we possess the strength, the cash flow, and the conviction to fund growth while returning value straight to shareholders. Looking forward, our priorities haven't shifted: produce strong financial results, broaden institutional uptake of longevity-based assets, and build lasting value for those who hold our shares. What our team has achieved makes me proud, and I'm even more enthusiastic about what lies ahead. So, we appreciate your joining today's call and we're ready for your questions.

Patrick Davitt

analyst
#6

Good evening, everybody. To start, I've got a handful of things to ask about the securitization. Number one, beyond the gain on sale, do you pick up any extra economics, such as a structuring fee or a transaction fee? Number two, can you tell us roughly how many big institutions took part, and how many of them were newcomers to the Asset Class? And last, might there be a chance to bundle more of these into a third-party asset management product of some kind that would let you charge fees? Thanks.

Jay Jackson

executive
#7

Sure. Hi, Patrick, and thanks. So, starting with the securitization, the first thing you asked about was any extra fees or outcomes we might see. One point worth making: we stay on as the servicer of the underlying assets. Going forward, we'll keep servicing fees on those assets, and that generates additional fee-related earnings tied to them. We also said, both in the initial press release and looking ahead, that we anticipate this kind of structure will keep expanding and be quite successful. It got a very strong reception. We deliberately made the initial offering somewhat smaller, at $50 million. Demand exceeded that — support beyond what we offered — so we could have brought a bigger product. When we thought about which partners to bring in for this, every one of them was new and actively investing directly into this kind of collateralized product. That encouraged us a great deal; they included insurance companies as well as commercial banks. On that note, I'd say that aspect was truly a part of this that worked out extremely well — you're seeing fresh adoption of the asset. Much of what they wanted was uncorrelated, or less correlated, yield within a rated structure. We expect this to keep growing as another distribution channel we can use to sell policies into and really aggregate policies into at an incredibly low cost of capital, which is also very compelling for us. Then I think the final piece was whether we'd see this structure expand into other Third-Party Funds. Absolutely, we're taking that into account, and there's been interest from other kinds of structures and vehicles seeking this sort of product, even inside their own Third-Party Funds. As we keep moving forward, I think what mattered was that completing this first one was hugely valuable, since we now have the platform in place so that effectively we can rinse and repeat, doing it again and at even bigger scale, which we expect to do on a regular basis. I'd anticipate seeing more of these on a steadier basis. Every quarter or every two quarters is roughly the goal.

Patrick Davitt

analyst
#8

Thanks, that's useful. And to follow up — it seems like the ad campaign has widened over the past 2 months, to the point that on certain days, while I'm working from home, it feels as though Jay is actually in my apartment. Could you maybe give us an update on whatever KPIs you have regarding that push translating into actual volumes? At this stage, with what appears to be a pretty significant increase in marketing spend, how are you gauging how well it's landing? Thanks.

Jay Jackson

executive
#9

Sure. Thanks, Patrick. As we move further into Q4, you'll generally notice bigger advertising pushes. Relative to our Origination, we've observed that this tends to be a bigger quarter for us. That leads me to this: if you take Q3 and set it against Q3 of last year, we're in fact up 10% for Q3 versus Q3 of last year; we sort of build up into some of that advertising as we head into Q4, since historically that quarter has been highly productive for us. And while I'm sorry about being in your living room, from a revenue standpoint I'm certainly not sorry, because it's working. That's wonderful news; we'll do our best to shut them off in your Zip Code.

Patrick Davitt

analyst
#10

Thanks a lot.

Jay Jackson

executive
#11

Thank you, Patrick.

Crispin Love

analyst
#12

Thanks. Good afternoon. To start, regarding money we put to work, it came to $102 million during the quarter, which is lower than what we saw in Q2, yet we still managed to generate quite strong life settlements revenues. Was the main reason for that the unusually large average gains during the period, or was it something different? I'm just interested in hearing about some of the pluses and minuses involved. And when it comes to what you expect going forward for capital deployed, does $120 million represent a reasonable run rate, or what's your view on that?

Jay Jackson

executive
#13

Sure. Yeah, you've got it exactly right. During Q3, should you observe it, the Adjusted EBITDA margin climbed to the greatest EBITDA margin we have ever recorded, surpassing 60%. Yes, we took a somewhat more strategic approach in Q3, when we identified certain highly attractive opportunities. We put that money to work. In the past, we've noticed that at times, when you consider Q3, especially as you approach the close of the summer months, you end up with a somewhat compressed window there before positioning for Q4. We're genuinely quite happy with how Q3 turned out in the end, and given the rise in margins, it simply made a great deal of sense to us. Regarding how we deploy capital strategically, we remain committed to being very deliberate and very shrewd about it. When it comes to a go-forward run rate, yes, as we examine Q4 of last year and set Q4 against this year, what we anticipate is that we will keep seeing this sustained and expanding from this point onward. A portion of that depends on capital, given the fresh capital we are clearly raising inside our Funds, yet that isn't the only factor — demand matters too. We're witnessing a fairly significant rise in demand from institutional capital seeking exposure to this Asset Class, because of the fundamental character of the Asset Class, which is that it offers an uncorrelated yield. Greater volatility in the market provides us with more opportunity not only to originate policies as individuals look for liquidity, but on top of that, to fill bigger Portfolios for Investment Funds that are looking to take advantage of this asset inside their own Funds. We anticipate that will keep expanding. We are certainly active out there, as Patrick has frequently mentioned, boosting our ad spend, and we can capitalize on that, I believe, effectively. As for the specific figure, whether it ends up being $120 million or a bit higher or lower than that, based on what we observe in Q4 or even moving forward, I believe that's a reasonable run rate. Clearly, we are pushing consistently to raise it. We're constantly aiming to raise it. I mean, if you examine this figure across the past two years, I mean, I believe we're at a 2x. Or perhaps even beyond that figure. Eventually, you move from 1.5 to 2x to where we stand now; we're beginning to observe some normalization and predictability as we forecast capital. That said, should additional opportunities arise over the coming, I believe, six months to one year, we might see that rise.

Crispin Love

analyst
#14

All right. So regarding keeping up and expanding from this point, more or less sustaining and building on that $102 million figure from Q3, would you say that's accurate?

Jay Jackson

executive
#15

Yes. What I'd suggest is taking a look at Q4 from the prior year, correct? And regardless of whether you examine Q2, when we exceeded $120, I'd say that's a reasonable approach for modeling where we believe we might land in Q4. Beyond that, however, I believe there are certain possibilities we're seeing in the marketplace as we keep applying our thinking around novel structures, such as securitizing this asset or employing a securitized-style format. In my view, Crispin will play a major role in shaping that figure for capital deployed, correct? What I mean is those two things will inevitably be interconnected. When it comes to your cost of capital, that will affect just how much additional volume you're able to originate. We'd anticipate that expansion to keep going.

Crispin Love

analyst
#16

Great, thanks. I appreciate that. Regarding the new dividend, could you tell us what you and the Board were thinking, and what you discussed compared with simply putting extra capital toward acquiring additional policies, doing more buybacks, or offering a smaller regular dividend? I'm just interested in your perspective on capital allocation, dividends, buybacks, and how capital gets used.

Jay Jackson

executive
#17

Of course. We gave the dividend a great deal of consideration. For a business like ours, an asset manager, paying dividends is pretty common. Something you'll notice is that as recurring revenue keeps increasing, our dividend as a share of that recurring revenue is right in line with what other asset managers pay. If you set that next to, say, our adjusted net income, we're very much on the conservative end. I believe, as you'd find across the market, we're in the low 20s when measured as a percentage of adjusted net income. 8% for that dividend. From a dividend standpoint, we saw this as a way to reward our shareholders thoughtfully while not taking anything away from the chances we had to bring in new contracts. This year, Crispin, based on our new guidance, we're targeting 80% growth year over year. And a modest dividend. I'd say our shareholders get the best of both worlds. This doesn't hold back our growth at all; we keep expanding and keep seeing that growth. When we examined our liquidity and then our recurring revenue, we concluded that for a company maturing over time into a bigger fee-related earnings business, the sensible next move was to hand those extra earnings to our shareholders through a dividend, and we'll make that payout yearly; as we noted in the press release, it will be based on, again, a highly conservative measure of under 25% of our adjusted net income, or 55% of our recurring revenue.

Crispin Love

analyst
#18

Okay, got it. Sorry to interrupt—just want to be clear on one thing. Is the payout going to happen every three months, or is it once a year?

Jay Jackson

executive
#19

It's paid once a year. Good catch on that. We made a deliberate decision to go with a yearly dividend rather than one each quarter, which gives us the chance to reinvest when attractive opportunities arise into some of those higher ROEs during the year, and after that, ultimately distribute that dividend to our investors. Doing it this way lets us get the most out of our capital growth while continuing to give a dividend and capitalization to our shareholders.

Crispin Love

analyst
#20

Thanks, Jay. I'm grateful that you're answering what I've asked.

Jay Jackson

executive
#21

Sure.

Mike Grondahl

analyst
#22

Hey, everyone. Nice work on the securitization this quarter. You provided quite a bit of useful detail about it. Could I ask you to take it a bit further? Regarding that $50 million securitization, might you discuss the unit economics along with the revenue and adjusted EBITDA generated by that deal? That way, as we consider 2026, whether you complete one every other quarter or one each quarter, we can get a feel for how it boosts the business.

Jay Jackson

executive
#23

Absolutely. I appreciate that question, Mike. Here's how to approach it: when examining unit economics for a securitization such as this one, I believe it's reasonable to state that going forward, we'll collect servicing fees just as we typically would with this type of product, correct? On a unit economics basis, the comparison I'd draw is that you'd actually view it as being just as profitable as a sale. What I mean is, given how we've established this structure, it's a true sale into a securitization; those unit economics are present. This is simply an additional structure we can employ to take advantage of that true sale and policy. If you look at our ROE and ROIC, those figures would essentially serve as a signal of how we're handling the unit economics of the securitization, since those policies are sold through a true sale into that vehicle. I hope that's clear. For us, the unit economics are highly attractive, just as they are for our business. What I believe the securitization accomplishes over the long haul is that it gives us greater consistency as time goes on, especially considering how often we're asked about sustaining the strength of our ROEs and ROICs. This structure delivers that across a very extended timeframe. I think that's something I'm genuinely enthusiastic about. When people examine our profitability or our margins, I believe this is an excellent structure that will let us preserve that profitability and those margins for many years ahead.

Mike Grondahl

analyst
#24

Great. Based on the slide deck about Abacus Wealth Advisors, it seems you've been making some headway. You've put a team in place, you're bringing on certain RIAs, and you have an AUM objective. Could you share a bit about the progress achieved so far?

Jay Jackson

executive
#25

Sure. Although there are quite a few possibilities we're currently evaluating that we can't reveal right now, we're extremely enthusiastic about how that part of our company is expanding. Something we pointed out was that AccuQuote came on board over time; and for the people we talk to, where we produce thousands of inquiries each month, AccuQuote was genuinely among our initial moves into asking whether we might serve that person's entire lifecycle and perhaps offer them a different insurance product rather than attempting to purchase a policy they might not be eligible for. That represented one of the earliest moves toward actually monetizing that connection with people who might not be eligible to sell their policy. Regarding wealth advisory, I know our deck contains what appears to be a fairly attractive five-year goal tied to diversifying our fee-related earnings. Our confidence in that remains strong. As I mentioned, there are quite a few possibilities we're evaluating at present. Our pipeline is strong, and it will keep growing. My confidence in the five-year goal we published concerning earnings is still very high. What matters most to us, I believe, is how extremely selective we are with every group we talk to, particularly regarding acquisition. You have to be, correct? They must be highly disciplined, and you must confirm it's the proper fit. You must confirm you're examining the sort of earnings you're after, since our margin here—an EBITDA margin of what, 60%? Not only us, but the majority of companies lack that sort of margin. Looking across the board, we want to be careful to try to capture and not give up our margin or adversely affect any other parts of our company. That's where a portion of the discipline comes in. We're ensuring we're seeking the appropriate kind of advisors who would suit that.

Mike Grondahl

analyst
#26

That works. Thanks.

Andrew Kligerman

analyst
#27

Hello, and good evening to all of you. The 37% realized gain really caught my attention, since it exceeded both last quarter and the same quarter a year earlier, each of which had topped out at 26%. Could you shed some light on what produced a gain that big? And what should we expect ahead — 37% each quarter?

Jay Jackson

executive
#28

Andrew, seriously—thanks for raising that question. That figure is substantial. One useful frame, I think, is what Elena mentioned when she spoke. Policies we'd sold spent slightly more time on the book this quarter—on average, roughly 363 days. When you allow those contracts to season a bit further, your spreads naturally widen. It really illustrates that plenty of strategy goes into making sure you sell and monetize contracts at the optimal moment, whether via new underwriting, added underwriting tied to premiums, or medical underwriting. And finally, as policies grow older and season, they become worth more by their very nature. Look back 12 months and consider where rates stood—or even beyond that, 18 months back, when we were actively acquiring some of these—well, not exactly 18 months, but definitely more than 12 months ago when we were acquiring these policies—we paid, in effect, a reduced price; now, with rates having moved favorably along with cost of capital, you can offload that identical contract at a wider spread; quite simply, that's what happened across this stretch. Rewind to our discussions 12 months ago—we'd essentially discussed this chance to acquire contracts at highly attractive pricing purely because of market conditions. We managed to seize that during Q3. If you're trying to gauge where we stand versus history, I'd say it's reasonable to note that in Q2 and Q1, tracking those, we always aim above 20%. Here, we captured somewhat more of that. I'd view our historical pattern as the benchmark.

Andrew Kligerman

analyst
#29

Appreciate that. You brought up the 363-day holding period. My sense is that early on, your aim was closer to around six months. And I believe during the prior quarter, you were considering letting things mature a bit further, since that ties directly into the point you just made. Jay, are you now leaning toward 363 days, or rather a full year, as being — No, I get it. Right. I get it, looking at the chart. Above the average realized gains, the holding period is shown; and if you check the remaining days held on owned policies right now, that figure sits at 253. From our standpoint, this quarter was possibly more opportunistic than what we saw in earlier periods. Being good stewards of capital means our task is to maximize revenue and maximize returns on the contracts we judge to be most sensible. More broadly, I'd say that if we keep deploying capital — through Funds, through securitizations, or as demand grows from institutional investors eager to put money into this product — the holding period may in fact decline, depending on how things look from the balance sheet side. For our strongest ideas, you would certainly see some of that. As Elena pointed out, that represented under 20% of our balance sheet — I'd describe those as policies that arrived quite late in the season, which matches where we've typically been. That figure hasn't shifted in any meaningful way. Given these structures, the hold period may indeed drop, driven by the demand we're seeing for balance sheet contracts. A hold period of roughly 250+ days, or perhaps even shorter.

Jay Jackson

executive
#30

Yeah.

Andrew Kligerman

analyst
#31

That helps. So I suppose, Jay, just one final thing — AccuQuote. Naturally, it's life insurance, though it isn't the same as the settlements business. Is there any — or maybe I overlooked it during the intro remarks — but do any overlaps exist where life settlements business could get a boost from AccuQuote? And second, I'm not sure whether you're able to share any of the economics, like what the price tag came to or anything along those lines, but that's something I'd be curious about if you could.

Jay Jackson

executive
#32

Absolutely — when it comes to synergies and crossovers, those certainly are present. There’s a really big group of people exploring multiple options for taking advantage of a newly issued policy, or perhaps, as time passes and that policy matures, potentially selling it. What we’ve discovered is that cross-selling possibilities exist across both books of business, though it needs to be approached very carefully. We’ve also been leveraging their team for several other tasks, particularly around client follow-up and education. There will be more updates on that later. What appeals to us most about that particular platform at the outset is keeping it centered on its core strength, which is taking advantage of and selling new term-style life insurance policies. Several companies out there, including SelectQuote and others, are running ads about this. Being able to provide that same kind of opportunity to our clients who call in but don’t qualify to sell their policy just seems extremely logical. I believe at first, we’ll be able to utilize AccuQuote for exactly what it’s built to do. There are certainly synergies moving forward when it comes to acquisition. Right now, we haven’t disclosed the economics related to the acquisition. I can say that in terms of acquisition size — meaning how large the acquisition was — it was fairly small, in the sense that it wasn’t material to either our earnings or our balance sheet; this wasn’t a — it wasn’t big enough that we were required to report on it, if that makes sense.

Andrew Kligerman

analyst
#33

Alright, that's useful, Jay. Appreciate it.

Timothy D'Agostino

analyst
#34

Hey there, thanks. So considering the $50 million securitization, if investor appetite continues to grow, could we potentially see larger deals later on, maybe in the $75 million range? Or would it just be more securitizations at the $50 million level? Thanks.

Jay Jackson

executive
#35

Thanks, Timothy. So the answer is that over time, larger securitizations will happen. I believe, as we mentioned earlier, the first securitization served to confirm the platform worked well, operated efficiently, and had demand. For that existing product, demand actually exceeds supply. My expectation is we'll see bigger securitizations, and they'll occur more often.

Timothy D'Agostino

analyst
#36

Okay, great. Let me follow up with another question. On slide 27 in the earnings deck, when I look at how many lives are tracked for ABL, it appears a large number shifted from in trial to paid lives. I'm curious how fast those converted from in trial to paid. What does the growth look like moving forward? Since clearly that in-trial figure has dropped now that they've been turned on. Thanks.

Jay Jackson

executive
#37

Excellent question. Thanks, Timothy. Yes. That can flip fairly fast. I mean, usually you'll see it happen inside the quarter. Someone stays in trial for 30 to 60 days. When that occurs, you'll bring on a new one. If you look at the actual pipeline behind the number of lives we genuinely serve, it's pretty significant. We're on track to exceed 3 million lives by the time Q4 wraps up. And since those people aren't in trial, doesn't that mean they could just be sitting in the pipeline without needing a trial at all? Our goal was simply to give a sense of what's coming. When I look at that chart, what strikes me is where this business was just a year ago. We're talking roughly a 20 to 30 times multiple versus the number of lives back then. This business is expanding exponentially. It's growing incredibly fast. Demand is through the roof. To reiterate, these agreements tied to SaaS span three to five years. Present were several of the nation's biggest pension funds. Without overstating it, that opens the door for our financial offerings to reach those very organizations, since we're now a sanctioned vendor able to present further ways they might engage with Abacus. Just in terms of generating top-tier leads, the value has been enormous.

Timothy D'Agostino

analyst
#38

Alright, fantastic, thanks a lot.

Jay Jackson

executive
#39

Thanks a lot, everybody. People are the foundation of what we do. And each individual working at Abacus, all of our staff, remember that close to 80% of our team holds this stock right next to you. Nothing feels better than being able to produce results like these. The reason we can produce them is that every person here operates as though they own this company. That's why, in my view, we get the outcomes we do; we can't wait to speak with you on upcoming calls. Should you wish to get in touch, feel free to contact our investor relations team. Accessibility is something we take great pride in. We're eager to talk with you again before long.

Operator

operator
#40

That brings this call to a close. We appreciate your joining us for today's presentation. You're free to disconnect at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.